RxDoctor Payments DataLook up a doctor →

Izervay: payments to doctors

Payments that named Izervay as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$5.4M
Providers
6,613
Transactions
19,548
Average per transaction
$275

The per-transaction average — $275 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,613 providers the average total is $812, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Astellas Pharma US Inc$4,817,12589.7%
Astellas Pharma Global Development$543,47010.1%
Astellas Pharma Europe Ltd$8,4480.2%
Astellas US LLC$1,6000.0%
← All drugs & devices